APOE and Alzheimer disease: There is increasing evidence that there are retinal manifestations of AD; the foveal avascular zone (FAZ) area is enlarged; retinal vessel density, central macular, and choroidal thickness are reduced in individuals with a genetic risk (apolipoprotein E; APOE e4) and first-degree family history of AD [14–17].